GREY:IMVIQ - Post by User
Comment by
bikkel78on Sep 10, 2019 3:30pm
200 Views
Post# 30113921
RE:RE:Quiet Board
RE:RE:Quiet Boardon Twitter IMV is more active, they really seems to be beating the drum. They also keep referring to Kite in 2015. I personally liked Fred mentioning that Merck will have to come to the table if the want the pivotal trial in DLBCL. And since Keytruda is not working in that field on itself....a deal has to come through. And Merck has to get the max out of Keytruda:
Instead, with the day at times resembling a tribute to Merck’s chief executive, Kenneth Frazier, it is clear that the group will aim to wring as much as it can out of Keytruda. Beyond that there was talk of vaccines and the chronic cough project gefapixant – showing just how hard an act to follow Keytruda will be.